New T-Cell Lymphoma Research Has Been Reported by Researchers at Chengdu University of Traditional Chinese Medicine (Inhibitory effect and related mechanism of decitabine combined with gemcitabine on proliferation of NK/T cell lymphoma cells).

Předmět:	T-cell lymphoma CHINESE medicine DECITABINE T cells CUTANEOUS T-cell lymphoma GEMCITABINE
Zdroj:	Hematology Week; 3/13/2023, p1424-1424, 1p
Abstrakt:	Human NK/T cell lymphoma cells NK92MI were treated with decitabine and gemcitabine alone or in combination. Keywords: Antimetabolites; Antineoplastics; Antivirals; Cancer; Cytometry; Decitabine Therapy; Drugs and Therapies; Gemcitabine Therapy; Genetics; Health and Medicine; Hematology; Immunoproliferative Disorders; Immunosuppressive Agents; Lymphatic Diseases and Conditions; Lymphoma; Lymphoproliferative Disorders; Oncology; Pharmaceuticals; Radiation-Sensitizing Agents; T-Cell Lymphoma EN Antimetabolites Antineoplastics Antivirals Cancer Cytometry Decitabine Therapy Drugs and Therapies Gemcitabine Therapy Genetics Health and Medicine Hematology Immunoproliferative Disorders Immunosuppressive Agents Lymphatic Diseases and Conditions Lymphoma Lymphoproliferative Disorders Oncology Pharmaceuticals Radiation-Sensitizing Agents T-Cell Lymphoma 2023 MAR 17 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- New study results on T-cell lymphoma have been published. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu